[1] 孔德华,张蕾,储静. 肿瘤化疗病人应用植入式静脉输液港与PICC临床效果的系统评价[J]. 护理研究,2018,32(9):1407-1414. Kong DH,Zhang L,Chu J.Clinical effect of venous-access ports and PICC in patients with tumor chemotherapy:a sys-tematic evaluation[J]. Chin Nurs Res,2018,32(9):1407-1414. [2] Ma L,Ge ZC,Xin L,et al.Clinical practice guidelines for breast cancer implantable intravenous infusion ports:Chinese Society of Breast Surgery practice guidelines 2021[J]. Chin Med J,2021,134(16):1894-1896. [3] Oh SB,Park K,Kim JJ,et al.Safety and feasibility of 3-month interval access and flushing for maintenance of totally implantable central venous port system in colorectal cancer patients after completion of curative intended treatments[J]. Medicine(Baltimore),2021,100(2):e24156. [4] 鲁佳,谢开红,陈文思,等. 肿瘤患者输液港相关性血栓预防及管理的最佳证据总结[J]. 中华护理杂志,2022,57(5):544-551. Lu J,Xie KH,Chen WS,et al.Evidence summary for the prevention and management of port-related venous throm-boembolism in cancer patients[J]. Chin J Nurs,2022,57(5):544-551. [5] 中华护理学会静脉输液治疗专业委员会. 临床静脉导管维护操作专家共识[J]. 中华护理杂志,2019,54(9):1334-1342. Chinese Nursing Association Intravenous Infusion Therapy Professional Committee. Expert consensus on venous catheter maintenance[J]. Chin J Nurs,2019,54(9):1334-1342. [6] Gorski LA,Hadaway L,Hagle ME,et al.Infusion therapy stan-dards of practice,8th edition[J]. J Infus Nurs,2021,44(1S Suppl 1):S1-S224. [7] López-Briz E,Ruiz Garcia V,Cabello JB,et al. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults[J]. Cochrane Database Syst Rev,2022,7(7):CD008462. [8] Hsieh HC,Hung SC,Huang SY,et al.A prospective,rando-mized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy[J]. J Chin Med Assoc,2022,85(1):114-119. [9] Gao XM,He R,Guan JF,et al.Effects of heparin catheter-sea-ling solution for implantable venous access ports on D-dimer levels in older cancer patients[J]. Eur Rev Med Pharmacol Sci,2017,21(3 Suppl):97-101. [10] Bertoglio S,Solari N,Meszaros P,et al.Efficacy of normal sa-line versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients[J]. Cancer Nurs,2012,35(4):E35-E42. [11] Goossens GA,Jérôme M,Janssens C,et al.Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients:a randomised,non-inferiority,open trial[J]. Ann Oncol,2013,24(7):1892-1899. [12] 焦俊琴,王建新,谢艳丽,等. 两种不同封管方法对植入式静脉输液港再通效果的研究[J]. 护士进修杂志,2012,27(17):1541-1543. Jiao JQ,Wang JX,Xie YL,et al.The effect of recanalization between two different methods of sealing the duct of the implantable vascular access devices[J]. J Nurses Train,2012, 27(17):1541-1543. [13] Wu XH,Chen LC,Liu GL,et al.Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients:a systematic review and meta-analysis[J]. Int J Nurs Pract,2021,27(2):e12913. [14] 张小红,梁冰,宋继红. 肿瘤患者应用静脉输液港两种封管方法效果观察[J]. 中华护理教育,2011,8(3):124-126. Zhang XH,Liang B,Song JH.Effects of two ways of tube sealing of vein transfusion port embedded in cancer patients[J]. Chin Nurs Edu,2011,8(3):124-126. [15] Soubirou JF,Commereuc M,Kofman T,et al.Should we use anticoagulant lock for short-term haemodialysis catheter in the ICU?[J]. Intensive Care Med,2014,40(6):912-913. [16] Rosenbluth G,Tsang L,Vittinghoff E,et al.Impact of decrea-sed heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients[J]. Pediatr Blood Cancer,2014,61(5):855-858. [17] Boord C.Pulsatile flushing:a review of the literature[J]. J Infus Nurs,2019,42(1):37-43. [18] Goossens GA.Flushing and locking of venous catheters:avai-lable evidence and evidence deficit[J]. Nurs Res Pract,2015, 2015:985686. [19] Pittiruti M,Bertoglio S,Scoppettuolo G,et al.Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters):a GAVeCeLT consensus[J]. J Vasc Access,2016,17(6):453-464. |